Purpose: To evaluate the optical performance of an enhanced monofocal intraocular lens (IOL) in the presence of cataract and a low degree of corneal astigmatism.
Methods: A prospective, comparative, nonrandomized study was conducted to compare the results of an enhanced monofocal IOL with a standard monofocal IOL in cases of cataract with corneal astigmatism ≥0.75 D and <1.5 D. A total of 38 patients meeting the inclusion criteria were enrolled in the study. Group A patients (19) were implanted with enhanced monofocal IOLs bilaterally, and Group B patients (19) received standard monofocal IOLs bilaterally. Both groups underwent standard procedures (phacoemulsification with IOL implantation in the capsular bag), and final outcomes were analyzed after a 3-month follow up. A P value < 0.05 was considered significant.
Results: The binocular uncorrected intermediate visual acuity, near visual acuity, and contrast sensitivity at 3 months was better in the enhanced monofocal group compared to the standard monofocal group (P < 0.001, P < 0.001, P = 0.02 respectively). The binocular uncorrected distance visual acuity at 3 months was comparable between the groups (P = 0.2); however, a higher number of cases attained visual acuity better than 6/9 in the enhanced monofocal IOL group. Post-operative higher-order aberrations were comparable between the groups. (P = 0.125).
Conclusion: Bilateral implantation of enhanced monofocal IOLs in patients with cataract and low degrees of corneal astigmatism demonstrates better tolerance to astigmatism compared to standard monofocal IOLs. In cases with <1 D corneal astigmatism, the enhanced monofocal IOL is the preferred choice over the standard monofocal IOL.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.4103/IJO.IJO_1639_24 | DOI Listing |
Front Med (Lausanne)
February 2025
Sussex Eye Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom.
Purpose: Mini-monovision is a vision correction technique that allows for a broader spectrum of spectacle independence while minimizing anisometropia. This systemic review aims to evaluate the clinical outcomes of pseudophakic mini-monovision with three types of intraocular lenses (IOLs): monofocal, enhanced monofocal, and extended depth of focus (EDOF).
Methods: A comprehensive literature search was conducted using PubMed and MEDLINE to identify studies reporting mini-monovision outcomes within the three categories of IOLs up to July 2024.
Clin Ther
March 2025
Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, Bocconi University, Milan, Italy; Department of Social and Political Sciences, Bocconi University, Milan, Italy.
Aim: Cataract is a prevalent health condition, primarily caused by aging, affecting approximately 95 million individuals worldwide. The only effective treatment currently involves surgically removing and replacing the crystalline lens with an artificial intraocular lens (IOL). Various IOLs are available, each with distinct characteristics, costs, and outcomes.
View Article and Find Full Text PDFIndian J Ophthalmol
March 2025
Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Purpose: To evaluate the optical performance of an enhanced monofocal intraocular lens (IOL) in the presence of cataract and a low degree of corneal astigmatism.
Methods: A prospective, comparative, nonrandomized study was conducted to compare the results of an enhanced monofocal IOL with a standard monofocal IOL in cases of cataract with corneal astigmatism ≥0.75 D and <1.
J Cataract Refract Surg
February 2025
Department of Ophthalmology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Purpose: To evaluate and compare visual performance of two enhanced monofocal intraocular lenses (IOLs), XY1-EM (Vivinex Impress, Hoya) and DIB00V (TECNIS Eyhance, Johnson & Johnson) with that of a conventional monofocal IOL, XY-1 (Vivinex, Hoya).
Setting: Kamiamakusa General Hospital, Kumamoto, Japan.
Methods: A retrospective analysis was conducted on 130 eyes from 75 patients, including 46 eyes (27 patients) implanted with XY1-EM, 47 eyes (26 patients) with DIB00V, and 37 eyes (22 patients) with XY-1.
Eye (Lond)
February 2025
Konyagoz Eye Hospital, Konya, Türkiye.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!